medRxiv · 2020 · 12 citations · 27 references
Veterinary MedicineInfectious DiseasesPathologyEarly DetectionMedical MicrobiologyVirologyAmyloid FormationCoagulation AbnormalitiesCoagulation DisordersInfectious Disease Molecular TestingViral InfectionsViral PathologyCoronavirus DiagnosticsRapid Detection AssaysSars-cov-2 Infection
Abstract The rapid detection of COVID-19 uses genotypic testing for the presence of SARS-Cov-2 virus in nasopharyngeal swabs, but it can have a poor sensitivity. A rapid, host-based physiological test that indicated whether the individual was infected or not would be highly desirable. Coagulaopathies are a common accompaniment to COVID-19, especially micro-clots within the lungs. We show here that microclots can be detected in the native plasma of COVID-19 patient, and in particular that such clots are amyloid in nature as judged by a standard fluorogenic stain. This provides a rapid and convenient test (P<0.0001), and suggests that the early detection and prevention of such clotting could have an important role in therapy.
27
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta, Daniel F. McAuley, Michael Brown et al. · The Lancet · 2020 · 10.2K citations · Full text
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Yanli Xu, Ruqin Gao, Roujian Lu et al. · JAMA · 2020 · 5.3K citations · Full text
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text
Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR
Yicheng Fang, Jicheng Xie, Minjie Lin et al. · Radiology · 2020 · 3.6K citations · Full text